178 related articles for article (PubMed ID: 6771804)
1. The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.
Silverman PB; Ho BT
Psychopharmacology (Berl); 1980; 68(3):209-15. PubMed ID: 6771804
[TBL] [Abstract][Full Text] [Related]
2. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus.
Winter JC
Psychopharmacologia; 1975 Oct; 44(1):29-32. PubMed ID: 1197576
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the discriminative stimulus properties of R-2,5-dimethoxy-4-methylamphetamine (R-DOM) and S-amphetamine in the rat.
Tilson HA; Baker TG; Gylys JA
Psychopharmacologia; 1975 Nov; 44(3):225-8. PubMed ID: 1208758
[TBL] [Abstract][Full Text] [Related]
4. Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats.
Tilson HA; Baker TG; Chamberlain JH
Psychopharmacologia; 1975 Nov; 44(3):229-39. PubMed ID: 1208759
[TBL] [Abstract][Full Text] [Related]
5. MDA and DOM: substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat.
Shannon HE
Psychopharmacology (Berl); 1980; 67(3):311-2. PubMed ID: 6770411
[TBL] [Abstract][Full Text] [Related]
6. Further investigation of the discriminative stimulus properties of MDA.
Glennon RA; Young R
Pharmacol Biochem Behav; 1984 Apr; 20(4):501-5. PubMed ID: 6728867
[TBL] [Abstract][Full Text] [Related]
7. MDA: a psychoactive agent with dual stimulus effects.
Glennon RA; Young R
Life Sci; 1984 Jan; 34(4):379-83. PubMed ID: 6694526
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
Glennon RA; Young R; Rosecrans JA
Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus properties of DOM and several molecular modifications.
Glennon RA; Young R; Rosecrans JA
Pharmacol Biochem Behav; 1982 Apr; 16(4):553-6. PubMed ID: 7071088
[TBL] [Abstract][Full Text] [Related]
10. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs.
Glennon RA; Yousif M; Patrick G
Pharmacol Biochem Behav; 1988 Mar; 29(3):443-9. PubMed ID: 2896360
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
Baker LE; Taylor MM
Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001
[TBL] [Abstract][Full Text] [Related]
12. 1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation.
Glennon RA; Young R; Soine W
Gen Pharmacol; 1984; 15(4):361-2. PubMed ID: 6149169
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic studies on DOM as a discriminative stimulus.
Glennon RA; Hauck AE
Pharmacol Biochem Behav; 1985 Dec; 23(6):937-41. PubMed ID: 2934750
[TBL] [Abstract][Full Text] [Related]
14. PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA.
Rangisetty JB; Bondarev ML; Chang-Fong J; Young R; Glennon RA
Pharmacol Biochem Behav; 2001; 69(1-2):261-7. PubMed ID: 11420094
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
Li JX; Unzeitig A; Javors MA; Rice KC; Koek W; France CP
J Pharmacol Exp Ther; 2009 Nov; 331(2):671-9. PubMed ID: 19687292
[TBL] [Abstract][Full Text] [Related]
16. Role of serotonin in the discriminative stimulus properties of mescaline.
Browne RG; Ho BT
Pharmacol Biochem Behav; 1975; 3(3):429-35. PubMed ID: 125425
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the behavioral effects of DOM homologs.
Glennon RA; Young R; Rosecrans JA
Pharmacol Biochem Behav; 1982 Apr; 16(4):557-9. PubMed ID: 7071089
[TBL] [Abstract][Full Text] [Related]
18. Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.
Appel JB; Callahan PM
Eur J Pharmacol; 1989 Jan; 159(1):41-6. PubMed ID: 2707301
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 2, 5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine for in vivo efflux of catecholamines from rat brain.
Vrbanac JJ; Tilson HA; Moore KE; Rech RH
Pharmacol Biochem Behav; 1975; 3(1):57-64. PubMed ID: 1129355
[TBL] [Abstract][Full Text] [Related]
20. Drug discrimination studies with MDMA and amphetamine.
Oberlender R; Nichols DE
Psychopharmacology (Berl); 1988; 95(1):71-6. PubMed ID: 2898791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
